Connect Biopharma Holdings Net Tangible Assets

Connect Biopharma Holdings (CNTB) currently reports a net tangible assets of $42M as of December 2025. That compares with $92M in the prior-year period — down 54.5% year over year. Use the charts on this page to explore Connect Biopharma Holdings's net tangible assets history and peer comparisons.

Connect Biopharma Holdings's net tangible assets decreased from $92M to $42M — a 54.5% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Connect Biopharma Holdings reported $42M in net tangible assets as of December 2025. That compares with $92M in the prior-year period — down 54.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Connect Biopharma Holdings, and consider following CNTB for alerts when major investors trade the stock.

Connect Biopharma Holdings is classified in the Healthcare sector. On net tangible assets, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNTB with unrelated industries.